|Articles|November 19, 2015
Michael J. Mauro on Questions From Patients With CML
Author(s)Michael J. Mauro
Michael J. Mauro, provides an overview of some of the questions he hears from patients with chronic myeloid leukemia (CML).
Advertisement
Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, provides an overview of some of the questions he hears from patients with chronic myeloid leukemia (CML).
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Keytruda Combo Approved for Platinum-Resistant Ovarian Cancer
2
FDA Grants Designation to Immunotherapy KB707 for Advanced NSCLC
3
Why Subcutaneous Darzalex Faspro Matters for Patients With Multiple Myeloma
4
FDA Fast Track Designation Highlights New Option in Advanced Liver Cancer
5